Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05LYC
|
|||
| Former ID |
DNC005055
|
|||
| Drug Name |
KR-62436
|
|||
| Synonyms |
KR-62436; CHEMBL184651; 761414-79-3; KR-60436 free base; SCHEMBL1083441; AOB5513; BDBM50150854; NCGC00165817-01; 6-{2-[2-(5-Cyano-4,5-dihydro-pyrazol-1-yl)-2-oxo-ethylamino]-ethylamino}-nicotinonitrile; 6-(2-(2-(5-cyano-4,5-dihydro-1H-pyrazol-1-yl)-2-oxoethylamino)ethylamino)nicotinonitrile; 3-Pyridinecarbonitrile, 6-((2-((2-(5-cyano-4,5-dihydro-1H-pyrazol-1-yl)-2-oxoethyl)amino)ethyl)amino)-; 1H-Pyrazole-5-carbonitrile, 1-(((2-((5-cyano-2-pyridinyl)amino)ethyl)amino)acetyl)-4,5-dihydro-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Non-insulin dependent diabetes [ICD-11: 5A11] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H15N7O
|
|||
| Canonical SMILES |
C1C=NN(C1C#N)C(=O)CNCCNC2=NC=C(C=C2)C#N
|
|||
| InChI |
1S/C14H15N7O/c15-7-11-1-2-13(19-9-11)18-6-5-17-10-14(22)21-12(8-16)3-4-20-21/h1-2,4,9,12,17H,3,5-6,10H2,(H,18,19)
|
|||
| InChIKey |
XNYVGGJJENHRBZ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 761414-79-3
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Dipeptidyl peptidase 4 (DPP-4) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Protein digestion and absorption | |||
| NetPath Pathway | IL2 Signaling Pathway | |||
| TGF_beta_Receptor Signaling Pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes. Bioorg Med Chem. 2009 Mar 1;17(5):1783-802. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.